Ironstomach
Key facts
- Where
- Helsinki, FinnországSee the site
- Phase
- 4. fázis
Where in Finnország
- HUS-YhtymaeHelsinki, FinnországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- HUS-Yhtymae
- Trial code
- EU 2024-519738-21-01
- Record updated
- 2024. december 16.
- Original description
TO investigate if preoperative iron infusion decreases the risk of transfusions and complications in after operation for gastric cancer.Read full original descriptionShow less
Preoperative intravenous iron therapy in patients with gastric cancer
TO investigate if preoperative iron infusion decreases the risk of transfusions and complications in after operation for gastric cancer.
Inclusion: Adult patients with gastric cancer.
Exclusion: Patients under 18 years old Patients not in full understanding Hemoglobin levels > 155 g/l for women and >167 g/l for men (upper reference limits for the laboratory of Helsinki University Hospital district) preoperatively. Transferrin saturation level >50% Emergency gastrectomy Palliative gastrectomy Acute bacterial infection Known hypersensitivity to the active substance, to ferric carboxymaltose or any of its excipients, or to other parental iron products Clinical evidence of iron overload or disturbances in the utilisation of iron Patients <35 kg Dialysis therapy for chronic renal failure Hemochromatosis Polycytemia vera Pregnancy Patients in need of direct blood transfusion.